Emergent BioSolutions (EBS) EBT Margin (2011 - 2026)
Emergent BioSolutions (EBS) posted quarterly EBT Margin of 8.58% for Q1 2026, down 3313.0% year-over-year from 0.27% in Q1 2025, and up 125.18% quarter-over-quarter from 34.1% in Q4 2025.
Emergent BioSolutions (EBS) EBT Margin (2011 - 2026) Analysis & Trends
Emergent BioSolutions' EBT Margin history runs 16 years deep, the most recent figure standing at 8.58% for Q1 2026.
- In Q1 2026, EBT Margin fell 3313.0% year-over-year to 8.58%; the TTM figure through Mar 2026 stood at 0.52% (up 871.0% YoY), while the FY2025 annual figure was 11.15%, up 2484.0% from the prior year.
- EBT Margin for Q1 2026 stood at 8.58%, up from 34.1% in the prior quarter.
- The five-year high for EBT Margin was 48.47% in Q3 2024, with the low at 539.6% in Q2 2024.
- The 5-year median for EBT Margin is 18.59% (2022), against an average of 49.64%.
- The sharpest annual moves came in 2024 and 2025: EBT Margin tumbled 46555 bps in 2024, then soared 52768 bps in 2025.
- Emergent BioSolutions' EBT Margin stood at 18.59% in 2022, then decreased by 6 bps to 19.7% in 2023, then rose by 28 bps to 14.18% in 2024, then plunged by 141 bps to 34.1% in 2025, then surged by 125 bps to 8.58% in 2026.
- Business Quant data shows EBS's EBT Margin at 8.58% in Q1 2026, 34.1% in Q4 2025, and 24.92% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -10.99% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 13.34% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 47.58% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -1.70% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 16.91% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 4.09% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn | -70.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -70.98% |
| Mar 31, 2026 | 8.58% |
| Dec 31, 2025 | -34.10% |
| Sep 30, 2025 | 24.92% |
| Jun 30, 2025 | -11.92% |
| Mar 31, 2025 | 41.72% |
| Dec 31, 2024 | -14.18% |
| Sep 30, 2024 | 48.47% |
| Jun 30, 2024 | -539.60% |
| Mar 31, 2024 | 4.03% |
| Dec 31, 2023 | -19.70% |
| Sep 30, 2023 | -98.30% |
| Jun 30, 2023 | -74.05% |
| Mar 31, 2023 | -97.75% |
| Dec 31, 2022 | -18.59% |
| Sep 30, 2022 | -28.01% |
| Jun 30, 2022 | -34.13% |
| Mar 31, 2022 | -1.25% |
| Dec 31, 2021 | 34.97% |
| Sep 30, 2021 | -15.89% |